Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Leaflet ANIDULAFUNGINA FRESENIUS KABI 100mg powder for concentrate for solution for infusion
- Product code:
- W66592001
- Quantity:
- 1
- Indicated for:
- invasive candidiasis; fungal infections
- Route of administration:
- infusion
- Substance:
- anidulafungin (antifungal)
- ATC
- J02AX06 — Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use
Precautions:
Anidulafungin is an antifungal medication used for the treatment of invasive fungal infections, such as invasive candidiasis and aspergillosis. It belongs to the echinocandin class and works by inhibiting the synthesis of beta-(1,3)-D-glucan, an essential component of the fungal cell wall. By disrupting the cell wall, anidulafungin causes fungal cell death.
Anidulafungin is administered intravenously, usually once daily, and the duration of treatment depends on the severity of the infection and the patient's response. It is primarily used in hospitalized patients, especially those with compromised immune systems.
Common side effects include nausea, diarrhea, headache, and injection site reactions. In rare cases, severe adverse reactions such as allergic reactions, hepatotoxicity, or electrolyte imbalances may occur.
Patients receiving anidulafungin should undergo regular monitoring for liver function and signs of adverse reactions. The medication is an effective and well-tolerated option for treating severe fungal infections, helping to reduce the mortality associated with these conditions.
Anidulafungin is administered intravenously, usually once daily, and the duration of treatment depends on the severity of the infection and the patient's response. It is primarily used in hospitalized patients, especially those with compromised immune systems.
Common side effects include nausea, diarrhea, headache, and injection site reactions. In rare cases, severe adverse reactions such as allergic reactions, hepatotoxicity, or electrolyte imbalances may occur.
Patients receiving anidulafungin should undergo regular monitoring for liver function and signs of adverse reactions. The medication is an effective and well-tolerated option for treating severe fungal infections, helping to reduce the mortality associated with these conditions.
General data about ANIDULAFUNGINA FRESENIUS KABI 100mg
- Substance:
- anidulafungin
- Date of latest medicines list:
- 01-02-2024
- Product code:
- W66592001
- Concentration:
- 100mg
- Pharmaceutical form:
- powder for concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.